menu
    • menu

    Company profile for Y-mAbs Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Y-mAbs has a powerful set of capabilities for the development of biologics. Our product development team includes some of the most talented and experienced professionals in the antibody industry.Through our collaboration with Memorial Sloan Kettering Cancer Center (MSK), Y-mAbs uses efficient methods for exploiting cell lines characteristics to rapidly raise monoclonal antibodies (mAbs) targeting cell surface proteins.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Y-mAbs TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    230 Park Avenue, Suite 3350 New York, NY 10169
    Telephone
    Telephone
    +1 646 885 8505
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ymabs.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Y-mAbs’s Biologics Danyelza Receives Suppl Approval in US
    Y-mAbs’s Biologics Danyelza Receives Suppl Approval in US

    27 Aug 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761171

    FDA
    27 Aug 2025
    Share Share
    Y-mAbs Announces Q2 2025 Financial Results and Corporate Updates
    Y-mAbs Announces Q2 2025 Financial Results and Corporate Updates

    08 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/08/3130042/0/en/Y-mAbs-Reports-Second-Quarter-2025-Financial-Results-and-Recent-Corporate-Developments.html

    GLOBENEWSWIRE
    08 Aug 2025
    Share Share
    Y-mAbs to Announce Q2 2025 Financial Results on August 8
    Y-mAbs to Announce Q2 2025 Financial Results on August 8

    07 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/07/3129120/0/en/Y-mAbs-to-Announce-Second-Quarter-2025-Financial-and-Operating-Results-on-August-8-2025.html

    GLOBENEWSWIRE
    07 Aug 2025
    Share Share
    SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics
    SERB Pharmaceuticals Agrees to Acquire Y-mAbs Therapeutics

    05 Aug 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/08/05/3127378/0/en/SERB-Pharmaceuticals-Agrees-to-Acquire-Y-mAbs-Therapeutics.html

    GLOBENEWSWIRE
    05 Aug 2025
    Share Share
    Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update on Pipeline
    Y-mAbs Hosts Virtual Radiopharmaceutical R&D Update on Pipeline

    28 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/28/3089277/0/en/Y-mAbs-Hosts-Virtual-Radiopharmaceutical-R-D-Update-Highlighting-Clinical-Progress-and-Expanded-Pipeline.html

    GLOBENEWSWIRE
    28 May 2025
    Share Share
    Y-mAbs to Host Virtual R&D Update on May 28, 2025
    Y-mAbs to Host Virtual R&D Update on May 28, 2025

    13 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/13/3079967/0/en/Y-mAbs-to-Host-Virtual-Radiopharmaceutical-R-D-Update-on-May-28-2025.html

    GLOBENEWSWIRE
    13 May 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search